BIOLASE Awarded Two New Patents

BIOLASE (NASDAQ: BIOL), theworld's leading manufacturer and distributor of dental lasers, announcedtoday that the U.S. Patent and Trademark Office ("USPTO") has awardedBIOLASE(R) two new patents. Patent 8,439,904 titled "Tapered Fused Waveguide for Teeth Whitening" isrelated to providing specially designed waveguide delivery systems which canbe coupled to lasers to deliver electromagnetic radiation to treatment siteswith relatively uniform power distributions over wide illumination areassuch as needed in tooth whitening and Low Level Laser Therapy ("LLLT"). Federico Pignatelli, Chairman and Chief Executive Officer, commented,"Patent 8,439,904 is the fourth patent we have been issued in this family.This patent significantly expands and strengthens our IP portfolio in thearea of applying laser energy to various parts of the body in order tooptimize the clinical effects of future bactericidal surgical and, at thesame time, whitening handpieces for dentistry, as well as additionalhandpieces for pain therapy, ophthalmology, and ENT." "The ability to design specifically shaped delivery systems and magnify theoutput of a laser to configure to specific anatomy for a particular medicalapplication is very important and this IP is being incorporated into anumber of our laser delivery devices currently in development," said DmitriBoutoussov, Chief Technology Officer. "It is rewarding that the USPTOcontinues to acknowledge our novel and innovative work which can be utilizedfor surgical, therapeutic, or diagnostic applications." Patent 8,419,719 titled "Target-Close Electromagnetic Energy EmittingDevice," a continuation of patent 7,815,630 with the same title, covers anumber of variations for having a battery operated laser guided with awireless transmitter and receiver controlled by a separate graphical userinterface ("GUI") unit. Examples of applications of this patent includemounting a laser and sterile delivery system for electromagnetic energy andfluids on the finger, hand, wrist, or eyeglasses and mounting the controlGUI on articles of clothing such as a belt, headband, or armband. "This broad new patent is an advanced and futuristic approach looking aheadto an era of wearable lasers. Such technology could have far-reachingapplications not only in hard- and soft-tissue procedures and pain therapyin dentistry and medicine, but could also be used in applications forscientific, industrial, and consumer products, as well, " Pignatelliconcluded. Additional claims specifically cover BIOLASE's unique ComfortPulse(TM) laserpulse characteristics included in the EPIC(R) , ezlase(R) , and iLase(R)soft-tissue diode lasers and diode laser wavelengths ranging from 915nm to980nm. About BIOLASE, Inc. BIOLASE, Inc. is a biomedical company that develops, manufactures, andmarkets lasers in dentistry and medicine and also markets and distributeshigh-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners;products that are focused on technologies that advance the practice ofdentistry and medicine. The Company's laser products incorporate over 350patented and patent-pending technologies designed to provide biologicallyclinically superior performance with less pain and faster recovery times.Its imaging products provide cutting-edge technology at competitive pricesto deliver the best results for dentists and patients. BIOLASE's principalproducts are dental laser systems that perform a broad range of dentalprocedures, including cosmetic and complex surgical applications, and a fullline of dental imaging equipment. BIOLASE has sold more than 22,500 lasers. Other products under development address ophthalmology and other medical andconsumer markets.